Glenmark Pharmaceuticals Ltd Board of Directors

Home

Insights

Board of Directors

₹ 2.5 Cr

Volume Transacted

(Nov 8, 2024)

14.7 K

Stocks Traded

(Nov 8, 2024)

Last Updated on: Nov 09, 2024

Board of Directors at Glenmark Pharmaceuticals Ltd

Name	Designation

B Saldanha	Non Executive Director
Cheryl Pinto	Executive Director (Corporate)
Dipankar Bhattacharjee	Independent Non Exe. Director
Glenn Saldanha	Chairman & Managing Director
Rajesh Desai.	Independent Non Exe. Director

Name	Designation
B Saldanha	Non Executive Director
Cheryl Pinto	Executive Director (Corporate)
Dipankar Bhattacharjee	Independent Non Exe. Director
Glenn Saldanha	Chairman & Managing Director
Rajesh Desai.	Independent Non Exe. Director

Open Demat Account

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

Key Highlights

Glenn Saldanha joins the board as Chairman & Managing Director, in a new position in 2024. This addition introduces a dedicated role focused on the company’s day-to-day operations and strategic implementation.
Cheryl Pinto continues to serve as the Executive Director (Corporate) in 2024, maintaining the same position as in the previous year.
V S Mani continues to serve as the Executive Director & Group CFO in 2024, maintaining the same position as in the previous year.
B E Saldanha continues to serve as the Non Executive Director in 2024, maintaining the same position as in the previous year.
Rajesh Desai. continues to serve as the Independent Non Exe. Director in 2024, maintaining the same position as in the previous year.

Glenmark Pharmaceuticals Ltd

NSE: GLENMARK

PRICE

Last updated on:

Last Ten Days Market Price

Date	Price (₹)	Day Open (₹)	Day High (₹)	Day Low (₹)

08 Nov 2024	1665.5	1670	1681	1647.65
07 Nov 2024	1657.7	1763.65	1771.95	1645.05
06 Nov 2024	1768.95	1734.85	1776	1723.6
05 Nov 2024	1724.9	1693.35	1737	1670
04 Nov 2024	1700.15	1687.05	1715	1650
01 Nov 2024	1690.95	1661.05	1699.35	1661.05
31 Oct 2024	1693.3	1666.55	1698	1666.55
30 Oct 2024	1670.9	1685.25	1695.2	1655.65
29 Oct 2024	1673.95	1724.6	1724.6	1628.55
28 Oct 2024	1714.5	1660.05	1721.9	1660

Date	Price (₹)
08 Nov 2024	1665.5
07 Nov 2024	1657.7
06 Nov 2024	1768.95
05 Nov 2024	1724.9
04 Nov 2024	1700.15
01 Nov 2024	1690.95
31 Oct 2024	1693.3
30 Oct 2024	1670.9
29 Oct 2024	1673.95
28 Oct 2024	1714.5

Company Fundamentals for Glenmark Pharmaceuticals Ltd

Market Cap

₹ 46,998 Cr

EPS

₹ 0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

6.0

Day’s High *

1681.0

Day’s Low

₹ 1647.65

DTE *

0.2

ROE *

-36.5

52 Week High

₹ 1830.05

52 Week Low

₹ 702.05

ROCE *

15.1

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Market Price Over Time

Monitoring Glenmark Pharmaceuticals Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Glenmark Pharmaceuticals Ltd News Hub

Glenmark Pharmaceuticals Ltd gains for third straight session

Glenmark Pharmaceuticals Ltd gained for a third straight session today. The stock is quoti...

06 Nov 202413:05

Glenmark Pharmaceuticals declare Quarterly Result

Glenmark Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 1...

31 Oct 202412:07

Glenmark Pharmaceuticals Ltd spurts 2.21%

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

08 Oct 202413:05

Glenmark Pharma spurts as Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the US ...

23 Sep 202410:12

Glenmark Pharma successful concludes USFDA inspection of its Aurangabad unit

Glenmark Pharmaceuticals announced that the United States Food & Drug Administration (USFD...

21 Sep 202412:53

Glenmark Pharma's Maharashtra facility clears USFDA inspection

The inspection was conducted from 9 September to 20 September 2024. In conclusion, the USF...

21 Sep 202416:30

Document

Annual Reports

Annual Report 2023

Credit Ratings

Credit Report 2023

Concalls

June 2024

May 2024

Feb 2024

Nov 2023

Sep 2023

Aug 2023

May 2023

Feb 2023

Nov 2022

Aug 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

May 2021

June 2024

May 2024

Feb 2024

Nov 2023

Sep 2023

Aug 2023

May 2023

Feb 2023

Nov 2022

Aug 2022

May 2022

Feb 2022

Nov 2021

Aug 2021

May 2021

Glenmark Pharmaceuticals Ltd market cap

Glenmark Pharmaceuticals Ltd share price history

Glenmark Pharmaceuticals Ltd isin code

Sun Pharmaceuticals Industries Ltd board of directors

Divis Laboratories Ltd board of directors

Cipla Ltd board of directors

Torrent Pharmaceuticals Ltd board of directors

Dr Reddys Laboratories Ltd board of directors

Mankind Pharma Ltd board of directors

Zydus Lifesciences Ltd board of directors

Lupin Ltd board of directors

Aurobindo Pharma Ltd board of directors

Alkem Laboratories Ltd board of directors

FAQs for Board of Directors of Glenmark Pharmaceuticals Ltd

How are members of Glenmark Pharmaceuticals Ltd Board of Directors selected?

Members of the Glenmark Pharmaceuticals Ltd Board of Directors are typically selected based on their expertise, experience, and alignment with Glenmark Pharmaceuticals Ltd’s strategic goals. Appointments are made by the nomination and remuneration committee and approved by shareholders. However, the selection process does vary from company to company.

Can shareholders interact with the Glenmark Pharmaceuticals Ltd Board of Directors?

Shareholders can interact with the Glenmark Pharmaceuticals Ltd Board of Directors during the Annual General Meeting (AGM) and through formal communications or queries submitted to the company wherein they have the opportunity to ask questions and provide feedback on the business. Please note different companies have different protocols for shareholders who want to meet the Board of Directors.

How often does the Glenmark Pharmaceuticals Ltd Board of Directors meet?

The Glenmark Pharmaceuticals Ltd Board of Directors typically meets quarterly. However, special meetings may be summoned as needed to address urgent matters. The frequency can vary depending on business needs and regulatory requirements to ensure ongoing oversight and strategic guidance for the company. A scheduled meeting among the Board of Directors may vary from company to company.

What are the responsibilities of the Glenmark Pharmaceuticals Ltd Board of Directors?

The Glenmark Pharmaceuticals Ltd Board of Directors is responsible for setting strategic goals, overseeing company performance, ensuring effective governance, and safeguarding shareholder interests. They provide high-level guidance on corporate policies and risk management. Additionally, they appoint and evaluate senior management and ensure compliance with legal and regulatory requirements. Please note the roles and responsibilities of the Board of Directors may be different from company to company.

Who are the current members of the Board of Directors at Glenmark Pharmaceuticals Ltd?

The current Board of Directors at Glenmark Pharmaceuticals Ltd includes Glenn Saldanha( Chairman & Managing Director) ,Cheryl Pinto( Executive Director (Corporate)) ,V S Mani( Executive Director & Group CFO) ,B E Saldanha( Non Executive Director) ,Rajesh Desai.( Independent Non Exe. Director) . The full list can be found on Glenmark Pharmaceuticals Ltd’s official website or recent corporate filings.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.

Unlimited trading at just

~~Rs. 399~~

Rs. 199*

Glenmark Pharmaceuticals Ltd Board of Directors

Board of Directors at Glenmark Pharmaceuticals Ltd

Key Highlights

Last Ten Days Market Price

Company Fundamentals for Glenmark Pharmaceuticals Ltd

PRICE

Market Price Over Time

Glenmark Pharmaceuticals Ltd News Hub

Document

Popular Search